A research team developing enzyme replacement therapies for people with rare diseases has been awarded £74,600 in funding from Scotland’s national economic development agency, Scottish Enterprise.
Almost 200 colleagues from academia and investment gathered at the University of Edinburgh today to celebrate and understand significant new research projects announced by the Centre for Investing Innovation, a strategic partnership between the University and abrdn, the Global Asset Manager.
Scottish scientists were at the SynBioBeta global life sciences conference in San Francisco in May to showcase world-class research and expertise in an area of crucial importance to the economy. We have much to be proud of, writesDr Susan Bodie, Head of Business Development for the College of Medicine and Veterinary Medicine at Edinburgh Innovations
Here in Scotland, we currently have a confluence of factors – data capacity, clinical and academic expertise, and technology – that put us in pole position to translate our excellent liver disease research and to develop the innovative new treatments we need, writes Dr Prakash Ramachandran, MRC Senior Clinical Fellow and Consultant Hepatologist at the University of Edinburgh...
Biotech companies for healthcare and sustainability and a social enterprise focused on the spice trade were the winners of this year’s Inspire, Launch, Grow awards for student enterprise.
The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organisation specialising in the advancement of cell and gene therapies, has opened a facility in the Edinburgh BioQuarter, its first site in Scotland.
NatWest Group and the University of Edinburgh have today announced a new partnership based on challenge-led research and innovation that will improve how data is used to benefit bank customers, students, researchers and policy makers.
No news categories with stories.
What’s your next challenge? Spin in, spin out or start up?
